iShares Health Innovation Active ETF is a ETF series of BlackRock ETF Trust (series S000069260). Net assets $10.1M as of 2026-04-30.
Showing 15 of 52 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Johnson & Johnson | — | $795K | 787.56% |
| Gilead Sciences Inc | — | $545K | 539.81% |
| Edwards Lifesciences Corp | — | $478K | 473.62% |
| Amgen Inc | — | $465K | 460.29% |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | — | $440K | 435.85% |
| Merck & Co Inc | — | $395K | 391.51% |
| Biogen Inc | — | $366K | 362.81% |
| Wuxi Biologics Cayman Inc | — | $325K | 321.67% |
| Waters Corp | — | $320K | 317.04% |
| Mettler-Toledo International Inc | — | $313K | 309.82% |
| Intuitive Surgical Inc | — | $298K | 295.10% |
| Charles River Laboratories International Inc | — | $298K | 294.90% |
| Vertex Pharmaceuticals Inc | — | $295K | 292.11% |
| Argenx SE | — | $288K | 284.96% |
| Moderna Inc | — | $267K | 264.12% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $10.1M |
| 2026-01-31 | $9.9M |
| 2025-10-31 | $5.7M |
| 2025-07-31 | $4.0M |
| 2025-04-30 | $2.9M |
| 2025-01-31 | $3.2M |
| 2024-10-31 | $4.1M |
| 2024-07-31 | $4.2M |